A Pilot Study of Donepezil Hydrochloride in Pediatric Brain Tumor Survivors After Cranial Irradiation.

Trial Profile

A Pilot Study of Donepezil Hydrochloride in Pediatric Brain Tumor Survivors After Cranial Irradiation.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2013

At a glance

  • Drugs Donepezil (Primary)
  • Indications Cognition disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 13 Apr 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 09 Dec 2008 Checked against ClinicalTrials.gov record.
    • 07 Jun 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top